American Healthcare REIT Announces Third Quarter 2026 Results; Increases Full Year 2026 Guidance
American Healthcare REIT reported Q3 2026 GAAP net income of $31.2M, or $0.14 per diluted share, and NFFO of $0.58 per diluted share. It acquired $1.69B in new investments and raised full-year 2026 guidance for Same-Store NOI growth to 12-14% and NFFO per share to $2.23-$2.26. The company also completed equity offerings and strengthened its leadership team. It reported a 0.6x improvement in Net Debt-to-Adjusted EBITDA to 1.9x as of Q3 2026.
How this was made
The 30-second read
Why it matters
The earnings beat and guidance raise expectations for higher dividend yields and share price appreciation.
Market read
AHR's results are material for REIT investors and may influence sector rotation toward healthcare real estate.
What to watch
Potential execution risk on the $1.69 B acquisition pipeline and future interest‑rate environment.
Background
AHR is a publicly traded U.S. REIT focused on senior housing and integrated health campuses.
Ticker impact
AHR reported Q3 2026 results and raised full-year 2026 Same-Store NOI growth and NFFO guidance, plus disclosed a $1.69 B acquisition program and new equity offerings.
likely upward pressure as investors price in higher NOI growth and cash from equity raises.
Guidance lift and sizable capital deployment indicate improved cash flow, supporting a bullish re‑rating.
Market effects
Boosts sentiment for the healthcare REIT sector and may lift peer senior‑housing REITs.
Positive for U.S. REITs and broader equity markets in the afternoon session.
Limited to U.S. real‑estate investors; no direct global macro effect.
Counterpoint
The aggressive equity raise could dilute existing shareholders and signal cash‑flow pressure.
Key entities
- ExecutiveJeff Hanson
CEO and Chairman of AHR, highlighted the quarter's performance.
- ExecutiveGabe Willhite
President and COO, discussed operational execution.
